{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-088689","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.421180+00:00","generated_at":"2026-05-31T14:27:20.694624+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TransMedics Q2 revenue $114.3M (+118% YoY), net income $12.2M, raises FY guidance","bullets":["Revenue $114.3M (+118% YoY); net income $12.2M ($0.35 diluted EPS) vs net loss $1.0M.","Gross margin 61% (down from 70% YoY) due to higher service revenue mix.","Operating expenses $56.8M (incl $7.3M stock comp) vs $37.6M prior year; driven by R&D and growth.","Raises FY2024 revenue guidance to $425M-$445M (76%-84% growth) from prior $390M-$400M.","Cash $362.8M as of June 30; owned 15 aircraft, purchased 2 more in July 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-088689","json":"https://secwatch.observer/filing/0000950170-24-088689.json","markdown":"https://secwatch.observer/filing/0000950170-24-088689.md","text":"https://secwatch.observer/filing/0000950170-24-088689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024088689/0000950170-24-088689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024088689/tmdx-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:27:20.694624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}